Pay in 4 interest-free payments of $7.17 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Anti-Inflammatory Role of Glucagon-Like Peptide 1 Receptor Agonists and Its Clinical Implications
The FDA has brought up some points about GLP-1 drugs and drug quality, such as: Adverse Events: There are growing reports about side effects like nausea, vomiting, and problems at the injection site
A quality product should disclose the amount of active glutathione, use a defensible formulation, remain stable through its expiration date, and be manufactured under appropriate current good manufacturing practices
Oral formulations were also developed.1,3,5 GLP-1 receptor monoagonists for the treatment of obesity: liraglutide and semaglutide The first molecule to be marketed for the treatment of obesity was liraglutide (LIRA), administered via daily subcutaneous injection, which became available in 2014
US$ 27.27
US$ 27.85
US$ 25.53
US$ 21.80
US$ 26.11
